Clinical Trials Browser

Interventional × Mastocytosis, Systemic × denileukin diftitox × Clear all

NCT00493129 2012-02-08

Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM)

Phase 2 Completed

LymphoidMyeloidOther hematologic neoplasm

Leukemia, Leukemia, Mast-Cell, Mastocytosis, Systemic